IMMUNOMODULATING AGENT, CELL ADHESION INHIBITOR AND AGENT FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE

PROBLEM TO BE SOLVED: To provide an immunomodulating agent, a cell adhesion inhibitor and an agent for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis. SOLUTION: A 4H-1-benzopyran-4-one derivative of formula or its salt has excellent immunomodulating action and ce...

Full description

Saved in:
Bibliographic Details
Main Authors AIKAWA YUKIHIKO, YOSHIDA CHOSAKU, TANAKA KEIICHI, MAKINO SHINJI, OSHIO ICHIRO, TANIGUCHI YOICHI, INABA TAKIHIRO, TAKANO SHUNTARO, SHIMOTORI TOMOYA
Format Patent
LanguageEnglish
Published 27.05.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract PROBLEM TO BE SOLVED: To provide an immunomodulating agent, a cell adhesion inhibitor and an agent for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis. SOLUTION: A 4H-1-benzopyran-4-one derivative of formula or its salt has excellent immunomodulating action and cell adhesion inhibiting action and is expectable to have an ameliorating effect on the autoimmune diseases except for rheumatoid arthritis comparable to the effect of steroid drugs. Accordingly, the 4H-1-benzopyran-4-one derivative of formula or its salt is useful for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis (such as systemic lupus erythematosus, scleroderma, mixed connective tissue disease, polyarteritis nodosa, multiple myositis/dermatomyositis, Sjoegren's syndrome, Behcet disease, multiple sclerosis, autoimmune diabetes, chronic thyroiditis, psoriasis, primary athyreosis, pernicious anaemia, myasthenia gravis, ulcerative colitis, chronic active hepatitis, autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura).
AbstractList PROBLEM TO BE SOLVED: To provide an immunomodulating agent, a cell adhesion inhibitor and an agent for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis. SOLUTION: A 4H-1-benzopyran-4-one derivative of formula or its salt has excellent immunomodulating action and cell adhesion inhibiting action and is expectable to have an ameliorating effect on the autoimmune diseases except for rheumatoid arthritis comparable to the effect of steroid drugs. Accordingly, the 4H-1-benzopyran-4-one derivative of formula or its salt is useful for the treatment and prevention of autoimmune diseases except for rheumatoid arthritis (such as systemic lupus erythematosus, scleroderma, mixed connective tissue disease, polyarteritis nodosa, multiple myositis/dermatomyositis, Sjoegren's syndrome, Behcet disease, multiple sclerosis, autoimmune diabetes, chronic thyroiditis, psoriasis, primary athyreosis, pernicious anaemia, myasthenia gravis, ulcerative colitis, chronic active hepatitis, autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura).
Author SHIMOTORI TOMOYA
TANIGUCHI YOICHI
OSHIO ICHIRO
INABA TAKIHIRO
TAKANO SHUNTARO
MAKINO SHINJI
YOSHIDA CHOSAKU
AIKAWA YUKIHIKO
TANAKA KEIICHI
Author_xml – fullname: AIKAWA YUKIHIKO
– fullname: YOSHIDA CHOSAKU
– fullname: TANAKA KEIICHI
– fullname: MAKINO SHINJI
– fullname: OSHIO ICHIRO
– fullname: TANIGUCHI YOICHI
– fullname: INABA TAKIHIRO
– fullname: TAKANO SHUNTARO
– fullname: SHIMOTORI TOMOYA
BookMark eNqNjM0KgkAUhWdRi358h0vrAlOk9c256g1nRnRsKxLTSlSw9yetHqDV-eE7ZytW_dC7jehYqVobZWSdo2WdAqak7RFiynNAmVHFRgPrjK9sTQmo5ReBZE62JLRqSUtflHSf_TIwCWBtzeedQHJFWNFerJ9tNznvpztxSMjG2cmNQ-OmsX243r2aWxH4fniOoiC8YPgX9AbM9jjl
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID JP2003155237A
GroupedDBID EVB
ID FETCH-epo_espacenet_JP2003155237A3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:08:43 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_JP2003155237A3
Notes Application Number: JP20020274477
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030527&DB=EPODOC&CC=JP&NR=2003155237A
ParticipantIDs epo_espacenet_JP2003155237A
PublicationCentury 2000
PublicationDate 20030527
PublicationDateYYYYMMDD 2003-05-27
PublicationDate_xml – month: 05
  year: 2003
  text: 20030527
  day: 27
PublicationDecade 2000
PublicationYear 2003
RelatedCompanies TOYAMA CHEM CO LTD
RelatedCompanies_xml – name: TOYAMA CHEM CO LTD
Score 2.5729795
Snippet PROBLEM TO BE SOLVED: To provide an immunomodulating agent, a cell adhesion inhibitor and an agent for the treatment and prevention of autoimmune diseases...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title IMMUNOMODULATING AGENT, CELL ADHESION INHIBITOR AND AGENT FOR TREATMENT AND PREVENTION OF AUTOIMMUNE DISEASE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030527&DB=EPODOC&locale=&CC=JP&NR=2003155237A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUYOipjFmTy4aNrbxQMxYOzbC1gUG4Y3APhKjGURm_Pe9VlCeeGv6cWkvvbtee_crwKORWHO06pZqpKml6rnWVBdtLVPnwjnI8NCv5yJ3OAgNb6z3p61pBd63uTASJ_RbgiOiRCUo76XU16v_SywqYyvXz4s3rFq-unGHKlvvGHdv01Rot8MiTrmjOE6nHynhULYJtDHNtA_gEM_RphAHNumKtJTVrk1xz-AoQnJFeQ6VrKjBibP9eq0Gx8HmxRuLG-FbX8CHHwTjkAecjgd27Ic9YvdYGD8Rhw0GxKYeE4qR-KHnd_2YD4kd0t8uBF09Eg-ZHQvoflmPnJ9gWQzgLsFdyiV1Rqg_YvaIXcKDy2LHU3Hasz8mzfrRzhK1K6gWyyKrA0H9kWoCNdRMLB3dl7bezs00NVpJrjfNxLyGxh5CN3tbG3AqY9teRFrbLVTLz6_sDm10ubiXvP0BXRiLiw
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8QjfimqFHxozFmTy4aNrbxQMxYOzbcugUK4Y3APhKjGURm_Pe9VlCeeGv6cWkvvbtee_crQg9GYs3AqluqkaaWqudaU523tUydCecgg0O_novc4ZAZ3kjvT1qTCnrf5MJInNBvCY4IEpWAvJdSXy__L7GIjK1cPc3foGrx4vIOUTbeMezepqmQbofGEYkcxXE6_VhhA9km0MY0095D-3DGNoU40HFXpKUst22Ke4wOYiBXlCeokhV1VHM2X6_V0WG4fvGG4lr4Vqfoww_DEYvCiIwCm_ush-0eZfwROzQIsE08KhQj9pnnd30eDbDNyG8XDK4e5gNqcwHdL-uB82MoiwGRi2GXRpI6xcQfUntIz9C9S7njqTDt6R-Tpv14a4naOaoWiyK7QBj0R6oJ1FAzsXRwX9p6OzfT1Gglud40E_MSNXYQutrZeodqHg-DaeCz1wY6knFuzyLF7RpVy8-v7AbsdTm_lXz-ARWrjn4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=IMMUNOMODULATING+AGENT%2C+CELL+ADHESION+INHIBITOR+AND+AGENT+FOR+TREATMENT+AND+PREVENTION+OF+AUTOIMMUNE+DISEASE&rft.inventor=AIKAWA+YUKIHIKO&rft.inventor=YOSHIDA+CHOSAKU&rft.inventor=TANAKA+KEIICHI&rft.inventor=MAKINO+SHINJI&rft.inventor=OSHIO+ICHIRO&rft.inventor=TANIGUCHI+YOICHI&rft.inventor=INABA+TAKIHIRO&rft.inventor=TAKANO+SHUNTARO&rft.inventor=SHIMOTORI+TOMOYA&rft.date=2003-05-27&rft.externalDBID=A&rft.externalDocID=JP2003155237A